Study of an investigational drug for chronic low sodium
Part of Kidney & urinary clinical trials.
This trial tests an investigational medication to see how the body processes it and its effects on chronic euvolemic hyponatremia, a condition of long-term low blood sodium that is not caused by fluid imbalance. Participation may help find a new treatment option for this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 85 years old
- You must have a diagnosis of chronic euvolemic hyponatremia (long-term low sodium with normal fluid balance)
- You cannot have low sodium caused by fluid overload (hypervolemic), dehydration (hypovolemic), or excessive water intake (psychogenic polydipsia)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called HRS-1780 in people with chronic kidney disease. It aims to see if the drug can help slow kidney decline and is safe to use.
This study looks at new ways to quickly check how well low sodium (caused by a common water pill called thiazide) is being treated in the hospital. If you have low sodium and take a thiazide pill, this trial may help doctors find better treatment methods.
This observational study measures how body fluid and electrolytes change in adults with low blood sodium caused by low “tonicity” (not diluted by high sugar or other causes). It may help clinicians better understand which treatment approaches keep sodium levels safer and more stable.
This study tests a new medication, RTN-001, for people whose blood pressure remains high even when taking multiple blood pressure medications. The goal is to see if this drug can lower blood pressure more effectively.
This study tests an experimental medicine called NNC0537-1482 for people with heart failure. It aims to see if the medicine helps improve symptoms and heart function.
This study tests a single dose of an investigational medicine (NNC0537-1482) to see how it moves through the body in people with different levels of kidney function. It may help researchers understand how the drug is processed so it can be dosed safely in future studies.
Hear when a new CHRONIC HYPONATREMIA trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.